Holen Sie sich die Stockscreener-App
14.64
3.43%
-0.52
Mediwound Ltd Aktie (MDWD) Neueste Nachrichten
Enterprise value to revenue forward of MediWound Ltd. – FWB:M8W - TradingView
MediWound Ltd.(NasdaqGM: MDWD) added to Russell 2000 Value-Defensive Index - marketscreener.com
MediWound Ltd.(NasdaqGM: MDWD) added to Russell 2000 Growth-Defensive Index - marketscreener.com
Price-Driven Insight from (MDWD) for Rule-Based Strategy - Stock Traders Daily
Mediwound Ltd (MDWD) Valuation: PE, PB & Fair Value Analysis - TradingKey
M8W Forecast — Price Target — Prediction for 2027 - TradingView
MediWound Ltd. Actuals & Estimates (NASDAQ:MDWD) - TradingView
Enterprise value to EBITDA forward of MediWound Ltd. – SWB:M8W - TradingView
MDWD Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of MediWound Ltd. – NASDAQ:MDWD - TradingView
Price to earnings forward of MediWound Ltd. – SWB:M8W - TradingView
Price to book forward of MediWound Ltd. – SWB:M8W - TradingView
Mediwound Ltd (MDWD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Mediwound Ltd (MDWD) Institutional Confidence - TradingKey
MediWound (MDWD) Holds Near Support After Marginal Gain, Biotech Sector in FocusGap Up Stocks - dars.gov.et
Mediwound Ltd (MDWD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Mediwound Ltd (MDWD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Mediwound Ltd (MDWD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mediwound Ltd (MDWD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mediwound Ltd (MDWD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mediwound Ltd (MDWD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MDWD Q1 2026 Earnings: Narrower-Than-Expected Loss Boosts SentimentEarnings Growth Analysis - newsline.com
MDWD Q1 2026 Earnings: Strong Beat on EPS Despite Narrower LossEarnings Per Share - newsline.com
MDWD Q1 2026 Earnings: Significant EPS Beat Drives Positive Sentiment Despite Absent RevenueCost Structure Review - newsline.com
MediWound Ltd. (MDWD) Q1 2026 Earnings: Narrowed Loss Surprises to the UpsideGeographic Revenue Trends - newsline.com
MediWound (MDWD) Sheds 1.87% as Stock Holds Above Key Support LevelAccumulation Line - newsline.com
MediWound Ltd. (MDWD) Retreats 1.87% as Price Tests Support Near $13.47Wave Equality - newsline.com
(MDWD) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Craig Hallum Forecasts MediWound's Q3 Earnings (NASDAQ:MDWD) - MarketBeat
Maxim Group Issues Negative Estimate for MediWound Earnings - MarketBeat
Insider Buying: Nachum Shamir Acquires 6,000 Shares of MediWound Ltd (MDWD) - GuruFocus
Director at MediWound (MDWD) buys 6,000 ordinary shares in market - Stock Titan
MediWound Ltd. Stock Plummets to New 52-Week Low of $13.58 - Markets Mojo
Insider Buying: David Fox Acquires Shares of MediWound Ltd (MDWD) - GuruFocus
Maxim Group Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $30 - Moomoo
MediWound (MDWD) director buys 3,537 ordinary shares on open market - Stock Titan
MediWound Q1 earnings call highlights - MSN
Director Rubinstein buys MediWound (MDWD) shares and holds multiple options - Stock Titan
MediWound Shares Slide This Week; BARDA Moves in Focus - Bez Kabli
MediWound Ltd. Hits New 52-Week Low at USD 14.14 - MarketsMojo
MDWD Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Operational EfficiencyEarnings Seasonality - newsline.com
MediWound (MDWD) Slips 1.58% as Stock Holds Near Critical Support at $13.61Price Momentum Stocks - The Legal Advocate
5 Stocks Better Than MediWound as Q1 Revenue Declines - HarianBasis.co
A. G. P. Maintains MediWound(MDWD.US) With Buy Rating, Cuts Target Price to $22 - Moomoo
MDWD Maintains Outperform by Oppenheimer -- Price Target Lowered to $32 - GuruFocus
MDWD Reiterates by HC Wainwright & Co. -- Price Target Maintained at $36 - GuruFocus
Oppenheimer Adjusts MediWound Price Target to $32 From $33, Maintains Outperform Rating - Moomoo
Oppenheimer Maintains MediWound(MDWD.US) With Buy Rating, Cuts Target Price to $32 - Moomoo
0.05%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):